Publication date: Jul 03, 2020 In multiple sclerosis (MS), medical comprehension of website information and informed consent is reported to be impaired. The aim of the present study was to ... Read more

Publication date: Jul 04, 2020 N-acylethanolamine acid amidase (NAAA) deactivates the endogenous peroxisome proliferator-activated receptor-? (PPAR-?) agonist palmitoylethanolamide (PEA). NAAA-regulated PEA signaling participates in the control of peripheral inflammation, but ... Read more

Publication date: Jul 06, 2020 Vaccines are key to preventing contagious, or serious, infections. However, their use in people with multiple sclerosis (pwMS) has often been problematic because of misguided ... Read more

Publication date: Jul 06, 2020 To investigate the action of cannabinoids on spasticity and pain in secondary progressive multiple sclerosis, by means of neurophysiological indexes. We assessed 15 patients with ... Read more

Publication date: Jul 07, 2020 Reduction in absolute lymphocyte count (ALC) is expected with fingolimod treatment. To evaluate the effect of fingolimod 0.5?mg versus intramuscular interferon ?-1a (30??g) on ALC ... Read more

Publication date: Jul 07, 2020 Fatigue is the most common symptom of MS and has no effective pharmacotherapy. To determine the tolerability, safety, and efficacy of low-dose ketamine infusion for ... Read more

Publication date: Jul 07, 2020 Paediatric multiple sclerosis (MS) is associated with higher relapse rate, rapid magnetic resonance imaging lesion accrual early in the disease course and worse cognitive outcome ... Read more

Publication date: Jul 07, 2020 Cognitive impairment is frequent in persons with multiple sclerosis (PwMS) and can impact on activities of daily living. The capacity to differentiate real changes from ... Read more

Publication date: Jul 02, 2020 The link between Toxoplasma gondii infection and multiple sclerosis remains controversial. In the present study, we aimed to determine the association between T. gondii seropositivity ... Read more

Publication date: Jul 02, 2020 Status quo (SQ) bias is defined as patient’s tendency to continue taking a previously selected but inferior therapeutic option. To assess the presence of SQ ... Read more